Home
About
Publications Trends
Recent Publications
Expert Search
Archive
crohn's disease
Which Cancers Are Most Common in Crohn's Disease Patients?
The most common cancers associated with Crohn's disease include:
Colorectal cancer
Small bowel cancer
Anal cancer
Lymphoma
The risk is particularly elevated in those with a long history of Crohn's disease, severe inflammation, and those who have a family history of colorectal cancer.
Frequently asked queries:
How Can Healthcare Providers Improve End-of-Life Care?
What are the Limitations of Medical Imaging Techniques?
Which Enzymes are Commonly Associated with Cancer?
What are Oncometabolites?
How Are Seed Grants Funded?
Why is Sentinel Lymph Node Biopsy Important?
Why is Pre Transplant Evaluation Important?
How is an IV Line Placed?
What is the Future of Biotechnological Methods in Cancer Treatment?
What Types of Data are Used in Computational Models?
What are the Symptoms of Pleural Mesothelioma?
What are Antigens?
How is LMWH Used in Cancer Patients?
What are the Advantages of Using Fluorescent Proteins?
What are the Benefits of Combining Radiation Therapy with Other Treatments?
How Can Patients Manage Eating Difficulties During Treatment?
How do oncology nurses manage chemotherapy administration?
What are the Challenges and Limitations of Using Bioreactors in Cancer Research?
Can the Tumor Microenvironment Affect Therapy Resistance?
What are Immune Checkpoint Molecules?
Top Searches
Brain Tumor
Breast cancer
cancer
Cancer Genomics
Chemotherapy
hepatocellular carcinoma
Lung Cancer
Nanotechnology
Non-Hodgkin’s Lymphoma
Radiation-Induced Malignancies
Follow Us
Facebook
Linkedin
Youtube
Instagram
Partnered Content Networks
Relevant Topics
4D Segmentation
Alopecia
Atlas-based Segmentation
Automated Segmentation
B-cell malignancies
biomarkers
Brain Tumor
Brain Tumor Segmentation
Breast cancer
cancer
Cancer Genome Atlas
Cancer genomics
Cancer treatment
CAR T-cell therapy
Carcinogenesis
cell adhesion
cell migration
chemotherapy
Chromatin remodeling genes
Chronic inflammation
CIAbimatoprost
Co-morbidity
Combination therapy
Copy number variations
cytokine release syndrome
Deep Learning
Diagnosis challenges
diffuse large B-cell lymphoma
DNA damage
docetaxel-cyclophosphamide
Drug delivery
epirubicin-cyclophosphamide
extracellular matrix
Fibrosis
Genetic alteration
Glioblastoma
Gold nanoparticles
Hepatocellular carcinoma
High Tumor
image-guided radiotherapy
Imaging Techniques
Immunosuppression
Immunotherapy
Integrative genomics
integrin inhibitors
Integrins
intensity-modulated radiation therapy
Keratinocyte
Lipid-based nanoparticles
liver cancer
long-term cancer risks
Lung cancer
Machine Learning
Magnetic Resonance Imaging
metastasis
methyltransferase
MRI
Multi-modal Imaging
Multidisciplinary care
Mutual exclusivity analysis
Nanoparticles
Nanotechnology
neoadjuvant radiotherapy
neurotoxicity
Next-generation sequencing
nnovative Biomarkers
Non-Hodgkin’s lymphoma
Novel Biomarkers for Brain Tumors
Novel Chemotherapy
Oncogenic transcription factors
oncological diseases
paclitaxel
Personalized medicine
Photobiomodulation therapy
Polymeric nanoparticles
portal vein tumor thrombus
Probabilistic Models
proton therapy
Radiation-induced malignancies
radiotherapy
refractory lymphoma
relapsed lymphoma
Risk factors
secondary cancer prevention
secondary cancers
Silver nanoparticles
stereotactic body radiation therapy
Targeted therapy
Tolerability
transarterial chemoembolization
Tuberculosis
tumor microenvironment
tumor progression
Voltage-gated sodium channels
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Cancer.
Subscribe